The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Association Between Travel Distance and Metastatic Disease at Diagnosis Among Patients With Colon Cancer
Open accessAbstract
Purpose: Health care access and advanced cancer stage are associated with oncologic outcomes for numerous common cancers. However, the impact of patient travel distance to health care on stage at diagnosis has not been well characterized. Methods: This study used a historical cohort of patients with colon cancer in the National Cancer Data Base from 2003 through 2010. The primary outcome, stage at diagnosis, was evaluated using hierarchical regression modeling. A secondary outcome was time to receipt of initial therapy that was evaluated using Cox shared frailty modeling. Results: Among 296,474 patients with colon cancer (mean age, 68 ± 13.6 years; 47.6% male; 78.5% white), 3.9% traveled ≥ 50 miles to the diagnosing facility. Fewer black patients, patients with higher income, and patients with lower education traveled longer distances (trend test P < .001 for all). Patients traveling ≥ 50 miles were more likely to present with metastatic disease compared with those traveling less than 12.5 miles (odds ratio [OR], 1.18; 95% CI, 1.12 to 1.24) or 12.5 to 49.9 miles (OR, 1.18; 95% CI, 1.12 to 1.24). In sensitivity analyses, the association was robust to alternate methods of modeling travel distance (quintile stratification or continuous). Travel distance ≥ 50 miles was also associated with a higher likelihood of earlier initiation of therapy compared with travel distance of less than 12.5 miles (hazard ratio [HR], 1.10; 95% CI, 1.08 to 1.13) or 12.5 to 49.9 miles (HR, 1.11; 95% CI, 1.08 to 1.13). Conclusion: Advanced colon cancer stage at diagnosis is associated with patient travel distance to health care, which may be a barrier to early cancer screening. Health care reform efforts designed to address only insurance coverage may not mitigate disparities based on difficulties accessing cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Unequal treatment: confronting racial and ethnic disparities in health care
(2003) · Choice Reviews Online · doi:10.5860/choice.40-5843 · Cited by 7,043
Distance to Diagnosing Provider as a Measure of Access for Patients With Melanoma
Stitzenberg, K. B., Thomas, N. E., Dalton, K., Brier, S. E., Ollila, D. W., Berwick, M., Mattingly, D., & Millikan, R. C. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.8.991 · Cited by 119
The developing vision of primary care.
Barnes, K. A., Kroening-Roche, J. C., & Comfort, B. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1204487 · Cited by 21
Cited by
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature
Ambroggi, M., Biasini, C., Del Giovane, C., Fornari, F., & Cavanna, L. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0110 · Cited by 545
Closing the Rural Cancer Care Gap: Three Institutional Approaches
Levit, L. A., Byatt, L., Lyss, A. P., Paskett, E. D., Levit, K., Kirkwood, K., Schenkel, C., & Schilsky, R. L. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00174 · Cited by 331
Lin, C. C., Bruinooge, S. S., Kirkwood, M. K., Olsen, C., Jemal, A., Bajorin, D., Giordano, S. H., Goldstein, M., Guadagnolo, B. A., Kosty, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.1558 · Cited by 263
Effects of payer status on breast cancer survival: a retrospective study
Shi, R., Taylor, H., McLarty, J., Liu, L., Mills, G., & Burton, G. (2015) · BMC Cancer · doi:10.1186/s12885-015-1228-7 · Cited by 60
Metadata
- Authors
- Massarweh, N. N., Chiang, Y.-J., Xing, Y., Chang, G. J., Haynes, A. B., You, Y. N., Feig, B. W., & Cormier, J. N.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-03-20
- Volume
- 32
- Issue
- 9
- Pages
- 942-948
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2145909848
- Cited by
- 175
- References
- 4
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.